Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited Financial Results ....
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed the stock exchanges that its Board of Directors will meet on Thursday, 12 February 2026. The main items on the agenda are to consider and approve the unaudited financial results for the quarter and nine months ended 31 December 2025. The Board will also consider declaring a 3rd interim dividend for FY25-26, if recommended. As per insider trading rules, the trading window for employees and connected persons is closed from 29 January to 14 February 2026, reopening on 16 February 2026.
This is a routine pre-results announcement; investors should watch for the actual Q3 numbers and any dividend declaration on 12 February, which could influence short-term stock sentiment.